{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:02Z","timestamp":1786991102243,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902422"],"award-info":[{"award-number":["81902422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20231245"],"award-info":[{"award-number":["BK20231245"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.intimp.2024.111611","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T08:06:05Z","timestamp":1707206765000},"page":"111611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients"],"prefix":"10.1016","volume":"129","author":[{"given":"Huaijuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9069-5907","authenticated-orcid":false,"given":"Xuebing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2024.111611_b0005","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2024.111611_b0010","doi-asserted-by":"crossref","unstructured":"R. Jenkins, J. Walker, U.B. Roy, 2022 cancer statistics: Focus on lung cancer. Future Oncol. 2023. Epub ahead of print. DOI: 10.2217\/fon-2022-1214.","DOI":"10.2217\/fon-2022-1214"},{"issue":"1","key":"10.1016\/j.intimp.2024.111611_b0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"issue":"16","key":"10.1016\/j.intimp.2024.111611_b0020","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.3390\/ijms241612622","article-title":"Immune Checkpoint Inhibitors in \u201cSpecial\u201d NSCLC Populations: A Viable Approach?","volume":"24","author":"Bronte","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.intimp.2024.111611_b0025","doi-asserted-by":"crossref","first-page":"11887","DOI":"10.3390\/ijms241511887","article-title":"Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability","volume":"24","author":"Tostes","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.111611_b0030","doi-asserted-by":"crossref","first-page":"121325","DOI":"10.3389\/fnut.2023.1213255","article-title":"Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors","volume":"10","author":"Yan","year":"2023","journal-title":"Front. Nutr."},{"issue":"Pt A","key":"10.1016\/j.intimp.2024.111611_b0035","article-title":"Novel evidence for the prognostic impact of \u03b2-blockers in solid cancer patients receiving immune checkpoint inhibitors","volume":"113","author":"Yan","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111611_b0040","article-title":"An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2024.111611_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108031","article-title":"Corticosteroid administration for cancer-related indications is an unfavorable prognostic factor in solid cancer patients receiving immune checkpoint inhibitor treatment","volume":"99","author":"Wang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111611_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106876","article-title":"Antibiotic administration shortly before or after immunotherapy initiation is correlated with poor prognosis in solid cancer patients: An up-to-date systematic review and meta-analysis","volume":"88","author":"Yang","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2024.111611_b0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/cancers15030591","article-title":"Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis","volume":"15","author":"Snijders","year":"2023","journal-title":"Cancers (basel)."},{"issue":"7","key":"10.1016\/j.intimp.2024.111611_b0060","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.3390\/curroncol30070500","article-title":"Cancer Pain Management: A Narrative Review of Current Concepts, Strategies, and Techniques","volume":"30","author":"Mestdagh","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.intimp.2024.111611_b0065","doi-asserted-by":"crossref","first-page":"e38167","DOI":"10.2196\/38167","article-title":"Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review","volume":"12","author":"Constance","year":"2023","journal-title":"JMIR Res. Protoc."},{"issue":"8","key":"10.1016\/j.intimp.2024.111611_b0070","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/COC.0000000000000714","article-title":"Impact of Pain, Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage IV Pancreatic Cancer","volume":"43","author":"Steele","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111611_b0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/s12885-023-11105-9","article-title":"The association between prescription drugs and colorectal cancer prognosis: a nationwide cohort study using a medication-wide association study","volume":"23","author":"Woo","year":"2023","journal-title":"BMC Cancer."},{"key":"10.1016\/j.intimp.2024.111611_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/rapm-2022-103769","article-title":"New, long-term opioid use after lung cancer surgery is associated with reduced 2-year survival: a retrospective population-based cohort study in South Korea","author":"Oh","year":"2022","journal-title":"Reg. Anesth. Pain Med."},{"issue":"10","key":"10.1016\/j.intimp.2024.111611_b0085","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1089\/jpm.2018.0044","article-title":"Opioid Dose and Survival of Patients with Incurable Nonsmall Cell Lung Cancer: A Prospective Cohort Study","volume":"21","author":"Hasegawa","year":"2018","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.intimp.2024.111611_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174284","article-title":"Concomitant use of analgesics and immune checkpoint inhibitors in non-small cell lung cancer: A pharmacodynamics perspective","volume":"906","author":"Prasetya","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.intimp.2024.111611_b0095","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1111\/1759-7714.14001","article-title":"Impact of concomitant medication on clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study","volume":"12","author":"Miura","year":"2021","journal-title":"Thorac Cancer."},{"issue":"e1","key":"10.1016\/j.intimp.2024.111611_b0100","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1136\/bmjspcare-2020-002480","article-title":"Opioids impair Nivolumab outcomes: a retrospective propensity score analysis in non-small-cell lung cancer","volume":"13","author":"Taniguchi","year":"2023","journal-title":"BMJ Support. Palliat. Care"},{"issue":"1","key":"10.1016\/j.intimp.2024.111611_b0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12967-021-02784-8","article-title":"The role of opioids in cancer response to immunotherapy","volume":"19","author":"Botticelli","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2024.111611_b0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.intimp.2024.111611_b0115","unstructured":"G.A. Wells, B.J. Shea, D. O'Connell, J. Peterson, P. Tugwell, The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. 2000."},{"issue":"D1","key":"10.1016\/j.intimp.2024.111611_b0120","doi-asserted-by":"crossref","first-page":"D1257","DOI":"10.1093\/nar\/gkac833","article-title":"Comparative Toxicogenomics Database (CTD): update 2023","volume":"51","author":"Davis","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.intimp.2024.111611_b0125","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.111611_b0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10822-016-9915-2","article-title":"TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models","volume":"30","author":"Yao","year":"2016","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.intimp.2024.111611_b0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejca.2021.08.036","article-title":"Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events","volume":"157","author":"Kostine","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.111611_b0140","doi-asserted-by":"crossref","first-page":"23331","DOI":"10.1038\/s41598-021-02598-0","article-title":"The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC","volume":"11","author":"Verschueren","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.111611_b0145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s12890-022-02210-9","article-title":"Impact of opioid analgesics on the efficacy of immune checkpoint inhibitors in a lung cancer population","volume":"22","author":"Yu","year":"2022","journal-title":"BMC Pulm. Med."},{"issue":"10","key":"10.1016\/j.intimp.2024.111611_b0150","doi-asserted-by":"crossref","first-page":"S713","DOI":"10.1016\/j.jtho.2019.08.1520","article-title":"Association Between Opioids and Outcome of 1st Line Immunotherapy in Advanced NSCLC Patients: A Retrospective Evaluation","volume":"14","author":"Bironzo","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.intimp.2024.111611_b0155","doi-asserted-by":"crossref","unstructured":"Y. Taniguchi, A. Tamiya, S. Isa, K. Nakahama, K. Okishio, T. Shiroyama, et al., P1.01-77 Impact of Oral Drugs on the Prognosis of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab. Journal of Thoracic Oncology. 2019;14(10, Supplement):S390.","DOI":"10.1016\/j.jtho.2019.08.792"},{"issue":"5","key":"10.1016\/j.intimp.2024.111611_b0160","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.athoracsur.2023.02.013","article-title":"Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection","volume":"116","author":"Zhou","year":"2023","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.intimp.2024.111611_b0165","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.3390\/curroncol30030262","article-title":"Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis","volume":"30","author":"Tan","year":"2023","journal-title":"Curr. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2024.111611_b0170","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/j.pain.0000000000001630","article-title":"Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer","volume":"160","author":"Nelson","year":"2019","journal-title":"Pain"},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.111611_b0175","doi-asserted-by":"crossref","first-page":"i88","DOI":"10.1093\/bja\/aeu192","article-title":"Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis","volume":"113","author":"Maher","year":"2014","journal-title":"Br. J. Anaesth."},{"issue":"1","key":"10.1016\/j.intimp.2024.111611_b0180","doi-asserted-by":"crossref","DOI":"10.1177\/1073274819871326","article-title":"Association of Opioid Use in the Week Before Death Among Patients With Advanced Lung Cancer Having Sepsis","volume":"26","author":"Choi","year":"2019","journal-title":"Cancer Control."},{"issue":"1","key":"10.1016\/j.intimp.2024.111611_b0185","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1186\/s12935-021-02334-8","article-title":"Morphine promotes the malignant biological behavior of non-small cell lung cancer cells through the MOR\/Src\/mTOR pathway","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.intimp.2024.111611_b0190","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/13813455.2020.1838552","article-title":"The effects of morphine on vascular cell adhesion molecule 1(VCAM-1) concentration in lung cancer cells","volume":"129","author":"Ghasemi","year":"2023","journal-title":"Arch. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2024.111611_b0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbrc.2020.08.038","article-title":"Fentanyl stimulates tumor angiogenesis via activating multiple pro-angiogenic signaling pathways","volume":"532","author":"Liu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2024.111611_b0200","doi-asserted-by":"crossref","first-page":"13131","DOI":"10.2147\/OTT.S281095","article-title":"Fentanyl Inhibits Lung Cancer Viability and Invasion via Upregulation of miR-331-3p and Repression of HDAC5","volume":"13","author":"Gong","year":"2020","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.intimp.2024.111611_b0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fonc.2019.00235","article-title":"Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis","volume":"9","author":"Wang","year":"2019","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2024.111611_b0210","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s00432-022-04513-0","article-title":"The negative impact of opioids on cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"149","author":"Ju","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.intimp.2024.111611_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106363","article-title":"The effect of opioids on the efficacy of immunotherapy in recurrent\/metastatic squamous cell carcinoma of the head and neck","volume":"140","author":"Scheff","year":"2023","journal-title":"Oral Oncol."},{"key":"10.1016\/j.intimp.2024.111611_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115417","article-title":"Immunosuppression by opioids: Mechanisms of action on innate and adaptive immunity","volume":"209","author":"Sun","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2024.111611_b0225","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3390\/cancers14092253","article-title":"Chronic Cancer Pain: Opioids within Tumor Microenvironment Affect Neuroinflammation, Tumor and Pain Evolution","volume":"14","author":"Santoni","year":"2022","journal-title":"Cancers (basel)."},{"key":"10.1016\/j.intimp.2024.111611_b0230","article-title":"Effect of Concomitant Use of Analgesics on Prognosis in Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis","volume":"13","author":"Mao","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.111611_b0235","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4103\/IJPC.IJPC_24_20","article-title":"Nonpharmacological Interventions for Pain Management in Lung Cancer Patients: A Systematic Review","volume":"26","author":"Kumar","year":"2020","journal-title":"Indian J. Palliat. Care"},{"issue":"4","key":"10.1016\/j.intimp.2024.111611_b0240","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/1759-7714.14758","article-title":"Circular RNA, circular RARS, promotes aerobic glycolysis of non-small-cell lung cancer by binding with LDHA","volume":"14","author":"Li","year":"2023","journal-title":"Thorac Cancer."},{"key":"10.1016\/j.intimp.2024.111611_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2022.170858","article-title":"Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3","volume":"156","author":"Moody","year":"2022","journal-title":"Peptides."},{"issue":"9","key":"10.1016\/j.intimp.2024.111611_b0250","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/JTO.0b013e3181834f52","article-title":"Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells","volume":"3","author":"Donnem","year":"2008","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2024.111611_b0255","doi-asserted-by":"crossref","first-page":"944","DOI":"10.21037\/tlcr-23-139","article-title":"Dynamic change of CD8(+) T cell: immunotherapy fate tell?","volume":"12","author":"Brueckl","year":"2023","journal-title":"Transl Lung Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.111611_b0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamaoncol.2022.4933","article-title":"Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC","volume":"9","author":"Rakaee","year":"2023","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2024.111611_b0265","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3390\/ijms24031897","article-title":"A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients","volume":"24","author":"Hannani","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T04:43:05Z","timestamp":1769229785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924001292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":53,"alternative-id":["S1567576924001292"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111611","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111611"}}